Work

Pharmacogenomic testing: Relevance in medical practice

Year: 2011

Type: article

Abstract: Genetics may account for much of the variability in our patients' responses to drug therapies. This article offers the clinician an up-to-date overview of pharmacogenomic testing, discussing implications and limitations of emerging validated tests relevant to the use of warfarin (Coumadin), clopidogrel (Plavix), statins, tamoxifen (Nolvadex), codeine, and psychotropic drugs. It also discusses the future role of pharmacogenomic testing in medicine.

Source: Cleveland Clinic Journal of Medicine

DOI: 10.3949/ccjm.78a.10145

Authors: Joseph P. Kitzmiller, David K. Groen, Mitch A. Phelps, Wolfgang Sadee

Institution: The Ohio State University

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institute of General Medical Sciences, National Center for Research Resources